© 2020 MJH Life Sciences and OncLive. All rights reserved.
July 24, 2019
Edward B. Garon, MD, MS, discusses the KEYNOTE-001 study, which examined the 5-year long-term overall survival in patients with non–small cell lung cancer treated with pembrolizumab.
February 11, 2016
The role of immunotherapy is emerging as
an effective, and in some cases, dramatic
treatment in the non-small cell lung